Long-term complete remission after severe pembrolizumab-induced immune-related encephalitis in metastatic lung adeno-squamous carcinoma: A case report
Authors:
Open Access
- 25 July 2023
- journal article
- research article
- Published by Elsevier in Respiratory Medicine Case Reports
- Vol. 45, 101898
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Atezolizumab-induced encephalitis in metastatic lung cancer: a case report and literature revieweNeurologicalSci, 2018
- A case of severe encephalitis while on PD-1 immunotherapy for recurrent clear cell ovarian cancerGynecologic Oncology Reports, 2018
- Immune-Related Adverse Events Associated with Immune Checkpoint BlockadeNew England Journal of Medicine, 2018
- Immune checkpoint inhibitors: new strategies to checkmate cancerClinical and Experimental Immunology, 2017
- Pembrolizumab-Induced Encephalopathy: A Review of Neurological Toxicities with Immune Checkpoint InhibitorsJournal of Thoracic Oncology, 2017
- Neurotoxicity from immune-checkpoint inhibition in the treatment of melanoma: a single centre experience and review of the literatureAnnals of Oncology, 2016
- Association of Autoimmune Encephalitis With Combined Immune Checkpoint Inhibitor Treatment for Metastatic CancerJAMA Neurology, 2016
- Central nervous system toxicities of anti-cancer immune checkpoint blockadeJournal of Neurology & Neuromedicine, 2016
- Neurological, respiratory, musculoskeletal, cardiac and ocular side-effects of anti-PD-1 therapyEuropean Journal of Cancer, 2016
- The blockade of immune checkpoints in cancer immunotherapyNature Reviews Cancer, 2012